ASX

articles with this tag

YPB Secures Vital Pharma Contract: Expects Circa $1M in Revenue

YPB Secures Vital Pharma Contract: Expects Circa $1M in Revenue

YPB Group Limited (ASX:YPB) has reinforced its relationship with leading Indonesian pharmaceutical and wellness company PT Combiphar, by signing a new three-year Master Services Agreement (MSA) that delivers the ASX listed technology company life of contract revenues of circa $1 million.

The ASX Company Changing the Game in Real-Time Healthcare Analytics

The ASX Company Changing the Game in Real-Time Healthcare Analytics

The company I’m looking at today comes with significant potential and is leading the way in informatics, a particularly lucrative area of healthcare that is seeing a rapid shift to digital patient data driven by the need for real-time healthcare analytics.

Thanks for subscribing!

X